Treatment-Related Cardiotoxicity in Non-Small Cell Lung Cancer: A Population-Based Analysis for Risk Stratification

Despite growing clinical recognition of treatment-related cardiovascular complications in NSCLC, large-scale evidence-based studies specifically targeting this population remain lacking. This critical knowledge gap persists particularly regarding specific cardiovascular toxicities such as cardiac arrhythmias, heart failure, pericardial diseases, cardiomyopathy, and coronary artery diseases.